Some issues in the design and analysis of equivalence trials

被引：0
|
作者：
Hauck, WW [1 ]
Anderson, S [1 ]
机构：
[1] Thomas Jefferson Univ, Div Clin Pharmacol, Biostat Sect, Philadelphia, PA 19107 USA
来源：
DRUG INFORMATION JOURNAL | 1999年 / 33卷 / 01期
关键词：
active control; bioequivalence; clinical equivalence; confidence intervals; intent-to-treat;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Given the number of approved drugs, it is increasingly the case that the comparison arm for a new drug or combination product is another drug or combination, that is, the trial uses an "active-control." Such active-controlled trials raise issues not seen in placebo-controlled trials. This note reviews and discusses some issues associated with the design and analysis of equivalence trials. Included are discussions of the choice of the equivalence allowance in designing the trial, and the roles of confidence intervals and intent-to-treat analyses.
引用
收藏
页码：109 / 118
页数：10
相关论文
共 50 条
  • [41] Cluster randomized clinical trials in orthodontics: design, analysis and reporting issues
    Pandis, Nikolaos
    Walsh, Tanya
    Polychronopoulou, Argy
    Eliades, Theodore
    EUROPEAN JOURNAL OF ORTHODONTICS, 2013, 35 (05) : 669 - 675
  • [42] Issues in the design and analysis of therapeutic trials in human immunodeficiency virus infection
    Babiker, AG
    Darbyshire, JH
    Peto, TEA
    Walker, AS
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1998, 161 : 239 - 249
  • [43] HIV VACCINE TRIALS - SOME DESIGN ISSUES INCLUDING SAMPLE-SIZE CALCULATION
    DIXON, DO
    RIDA, WN
    FAST, PE
    HOTH, DF
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (05): : 485 - 496
  • [44] ISSUES IN THE DESIGN OF DRUG TRIALS FOR AIDS
    GREEN, SB
    ELLENBERG, SS
    FINKELSTEIN, D
    FORSYTHE, AB
    FREEDMAN, LS
    FREEMAN, K
    LEFKOPOULOU, M
    SCHOENFELD, D
    SMITH, RP
    CONTROLLED CLINICAL TRIALS, 1990, 11 (02): : 80 - 87
  • [45] Methodological issues in the design of clinical trials
    Fine, PG
    ASSESSMENT AND TREATMENT OF CANCER PAIN, 1998, 12 : 189 - 194
  • [46] Design issues in cancer screening trials
    Moss, Sue
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2010, 19 (05) : 451 - 461
  • [47] DESIGN ISSUES IN TRIALS OF SMOKING CESSATION
    SINGER, J
    WILSON, D
    BEST, JA
    TAYLOR, DW
    GILBERT, JR
    LINDSAY, EA
    WILLMS, D
    CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 247 - 248
  • [48] LOGIC EQUIVALENCE CHECK IN SOC DESIGN: SOLUTION AND ISSUES
    Zhu, Qing K.
    CIICT 2008: PROCEEDINGS OF CHINA-IRELAND INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATIONS TECHNOLOGIES 2008, 2008, : 623 - 626
  • [49] DESIGN OF CLINICAL-TRIALS - ACTIVE CONTROL (EQUIVALENCE) TRIALS - OPEN DISCUSSION
    CHALMERS, T
    WITTES, R
    FLEMING, T
    HEATHCHIOZZI, M
    RIOS, A
    RICHMAN, D
    JAMES, J
    TEMPLE, R
    ELLENBERG, S
    BOZZETTE, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S92 - S94
  • [50] An alternative view of some FIA sample design and analysis issues
    Van Deusen, PC
    PROCEEDINGS OF THE FOURTH ANNUAL FOREST INVENTORY AND ANALYSIS SYMPOSIUM, 2005, 252 : 187 - 191
12345